Jan 29, 2020
Immutep Activities Report
Jan 08, 2020
Immutep Expands Part C of TACTI-002 Due to Positive Data
Dec 18, 2019
INSIGHT-004 Clinical Trial Update
Nov 13, 2019
Immutep Announces European Patent Grant for LAG525 Antibody
Nov 07, 2019
Immutep Presents Positive Interim Data from Phase II TACTI-002 Trial at SITC
Oct 28, 2019
Operational Update
Oct 14, 2019
Immutep Reports Positive Final Efficacy Data from TACTI-mel Trial in Melanoma
Oct 09, 2019
Immutep Announces Data Presentations at Upcoming Industry Conferences
Immutep Receives A$2.5 Million R&D Tax Incentive from French Government
Sep 25, 2019
Immutep Announces Expansion of Part A of TACTI-002 Phase II Clinical Trial due to Positive Interim Data
Sep 22, 2019
Immutep to Receive £4M Milestone Payment from GSK
Sep 16, 2019
Immutep Announces Japanese Patent Grant for LAG525 Antibody
